PDSB | PDS Biotechnology

Healthcare sector

• Summary
• Earnings Call
• Events
• Charts
• Historical Data
• Dividends
• Upgrades
• Profile

Category: Biotechnology company

• Industry: Biotechnology

Quick infos

• Headquarters:   Berkeley Heights, New Jersey, United States

Trade prices

• Volume:
• Market Cap: 104.98M
• Prev closed: 0.87
• Open: 0.89
• High: 0.9
• Low: 0.83
• 52 week low: 0.62
• 52 week high: 9.45
• Dividends:No Dividends

Next ER: May 15, 2023  Before Market Opens

Top Stories (PDSB)

Company Profile

PDS Biotechnology has a growing pipeline of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, cervical cancer, anal cancer, prostate cancer, breast cancer and other cancers.

Earnings History

Date	EPS / Forecast	Revenue / Forecast
August 9, 2023
May 15, 2023	-0.32 / -0.33	- / -
March 28, 2023	-0.65 / -0.2838	- / -
November 14, 2022	-0.26 / -0.28	- / -
August 8, 2022	-0.2 / -0.2817	- / -
view more

NASDAQ - Nasdaq Stock Market

News

News for (PDSB)

• PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck Cancer in Collaboration with Merck
  finance.yahoo.com Nov 9, 2020 4:05 pm
• PDS Biotechnology Announces Feature in Grand Rounds Webinar hosted by Alliance Global Partners and Conference Call and Webcast for Third Quarter 2020 Financial Results
  finance.yahoo.com Oct 29, 2020 4:30 pm
• PDS Biotechnology Announces Participation in Noble Capital Markets Virtual Road Show Series
  finance.yahoo.com Oct 1, 2020 8:30 am
• PDS Biotechnology to Participate in Upcoming Healthcare Investor Conferences
  finance.yahoo.com Sep 8, 2020 4:05 pm
• 
  PDS Biotechnology reports Q2 results
  seekingalpha.com Aug 13, 2020 6:02 pm
• PDS Biotechnology Corporation Announces Closing of Approx. $19 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares
  finance.yahoo.com Aug 13, 2020 4:05 pm
• PDS Biotechnology Announces Resignation of James Loughlin from Board of Directors
  finance.yahoo.com Aug 13, 2020 4:05 pm
• PDS Biotechnology Signs Cooperative Research and Development Agreement with National Cancer Institute to Perform a Phase 2 Clinical Study of PDS0101 in Combination with Other Immune-modulating Agents in Advanced HPV-related Cancers
  finance.yahoo.com Aug 13, 2020 8:30 am
• 
  PDS Biotechnology under pressure after pricing $16.5M stock offering
  seekingalpha.com Aug 11, 2020 9:47 pm
• 
  PDS Biotechnology readies equity offering
  seekingalpha.com Aug 11, 2020 8:27 pm
• PDS Biotechnology Corp. Announces Clinical Collaboration with Merck
  finance.yahoo.com Aug 13, 2020 8:30 am
• PDS Biotechnology Reports Financial Results for the First Quarter 2020 and Provides Business Update
  finance.yahoo.com Aug 13, 2020 6:00 am
• PDS Biotechnology Reports Financial Results for the Second Quarter 2020 and Provides Business Update
  finance.yahoo.com Aug 13, 2020 6:00 am
• PDS Biotechnology Corporation Announces Pricing of $16.5 Million Public Offering of Common Stock
  finance.yahoo.com Aug 11, 2020 9:05 am
• PDS Biotechnology Corporation Announces Proposed Public Offering of Common Stock
  finance.yahoo.com Aug 10, 2020 4:05 pm
• PDS Biotechnology Reports First Quarter 2019 Financial Results and Provides Business Update
  finance.yahoo.com Aug 9, 2020 4:10 pm
• 3 Strong Buy Healthcare Stocks Under $5 That Could See Outsized Gains
  finance.yahoo.com Aug 6, 2020 5:19 pm
• PDS Biotechnology Announces Conference Call and Webcast for Second Quarter 2020 Financial Results
  finance.yahoo.com Jul 30, 2020 4:05 pm
• 
  PDS Biotech COVID-19 vaccine candidate shows encouraging preclinical action
  seekingalpha.com Jul 27, 2020 9:47 pm
• PDS Biotech Announces Preclinical Data for PDS0203, a T-Cell Activating Recombinant Protein Vaccine Against COVID-19
  finance.yahoo.com Jul 27, 2020 8:30 am

This company doesn't provide a dividend.

Talk about PDS Biotechnology below in comments section below.

Do you think you'll buy? Do you already have active trades now?

EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.

Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.

Other ER on May 15, 2023 (Same day)